ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001335.1|Borregomycin_1 # 1 # 2877 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.762	BGC0001335.1|Borregomycin_1 	1	2877	+	Loose	390	32.3426	evgA	30.77	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTGGGTAACGGGGGACATGAAGACTCTGCCGGGTCGTCTTGAGGAAAGGTCAGTCACCGTCATCGATCGCCCCGATCCGCCACTGCGCAACAGGGACGCGCAGCTGGCCCGGATCGAGGCCGTACTGCGGCCGGTCGGCGCCACCGGGAAGAGCGCCGTCCTGCTGGCCGAGGGGCCGGCCGGGAGCGGCAAGTCGCGTCTGGTGGCCGAGGCTGCCCGGCTCGGTGCGGATCAGGGGTACACCGTGCTGCGCGGCGCCGCGAGCCGGCTCACCCAGCAGATCCCGATGGCGCCGCTGCTGGCCGCGCTGGCCGTGCCGGCGCCCGCGCCGGAGCCGAACTCCACCGACGTGCTCGACCGGCAGCTGGGCGTGGTGGGCCGGCTCGAGGTCCGGCTGCGCGAGCGGCTGCGCACCGGACCGGTCCTGGTCGCGCTCGACGACCTGCAGTGGGCCGACCCGGCGACGCTGCTGGCGCTGCGCATGTTGTGCTCCCGGCTGGCCGGCGCACCGGTGGTCTGGCTGCTGGTCCTGCTCGGCGGGGACCGGTCGCAGGAGCTCGACCTGCTCTTCGACGCCCTCCGCGGCCGGGCCCACACCGAGCGGCTCGATCCGCTGGCGCCGCTGTGCGACCGCGCCTCGGTGCAGCTGGTGACGGACGTGCTCGGCGCGCCGCCGGGCCCCGAGATCAGCGAGCTGGTCGAGAGCACCAACGGCAACCCCCGGGTCGTCATCGACCTGGTGACCGGCATGCGCGACGACGGCGCCATCCGGGTCGTCGACGGCGTGGCCCGGCTGGCCGCCGTACCGGCCATCGGGCTGGCCGCCGGCGCGGCGGACCGGCGCTCGCCCGGGCCGCTGCCCGCCCGGTTCCGGGCCCTGATCGGCGCGGAACTCGCCGCCCTGTCCCCCGCCACCCGCCAGATGGTGCAGGTCGCGGCGGTGCTCGGCGTCTCGTTCAGCCCGGACGACCTGTGCGAGATGCTCGGCGAGCCGCCGTCTCGCCTGCTGCCGGTGATGCAGGAGGCATTGCATTCCGAGCTGATGTTCAGCCGGCTCGACGACTTCGCGTTCCGGCGCGAGCCGGTGTGGCGGGCGGTGCTGGACACCGTGCCGATGCCGGTCCGGGTGGCGATGCACCGGCAGGCCGCCGACATGCTGCTGCGGCGCGAGGGCGGCATCATGGCCGCCGCCACGCACCTGGTGCACGGGGCGCTGCCGGGCGACGCCCTCGCCGTCGACCTGCTCGGCCGGGCGGCCGAGCAGGTGCTCACCACCTCGCCGCGGACGGCCGTCACGCTGGCGTCGCGCGGGCTGGAGCTCTCCGAGCCTCAGCAGCCCGGGTATCTGCAGCTGGCAGTCACCGCCGTGCGGGCGTTGAATCACGCGGGCCCGTTGGACCGGGCCGCCCACGTCGCCACCGAGGTGCTGGACGAGGTCCGGCCCGAGGGCGAGGCCGGGGCCCGGCTGCGGCAGCTGCTGTCGACCACCCTGCTGCTGCAGGGCCAGGCCGGGCGCGGCAGCGGGCTGGCCCGGCAGATCCTCGCCGATCCGCGGCTCGGCCCCGAGCTGCGCGACGGGGCCGAGGTGGTCCAGCTGGTCGCGCTGTCGCACACCGACGAACGCGCCGCCTACCAGCGGGCCGACGCGGTGCTCGCGGAGCGCTCGGGGCGCGGGGCGGCCGTCGCGGCGATCGCCCTGACCGTCCGGGCGGTGGGACAGTGGCGGGAGGGCCGCGTCGGCGACGCGTTGCGGACGGTCGACGAGGCCGGCTCACTGCTCGGCGACGGCACGGACACCTGGCACAGCGATCCGCGGTGGACCGGCGCGCTGATGCGGCTGCGGCTGCGCAAGCTGGCCGAGGCCACCGACATGATCACCGCCTGCACCACGGCCGCCGAGGAACGCGGCGCCGACGTGGTCGCCGCGGTGCCGGCCATCCTGCGCTCCGGGGTCCACCTGGCCCGGGGCGAGCTGGCCGAGGCGGAGGCCGCCGCCCGGGCCGGCGTCTCCGCCGGGGCCGACCACCACATGCCGCTGTTCGCGCCGCTGGCCTGGGCGGTGCTGACCACCACCGCGCTGCGCGGCGGCGACCTGATGGCGGCCGGCGAACACGTCCGGGAGCTGGACCGTACGGTGCTCGACCAGAGCTCCCGGCCGTGGTGGGCGCTGCGGATCTGGGTGGCCGCCCGGGTCGCCGGTGCCCGGGACGGCGCCGCCGCCGCGATGGGTGTGCTGGTCGAGGGCTACCGCGACGCGGGTGCCCGCCGCGAACTGCTTTTGGAGGACTACGCCGCCGCGGCCTGGTGTGTGCGGGCCGCGCTCGAGGCCGGCCTGCCGGACATCGCCCATGCCCTGGCCGAGACCGCGCACGCGCTGGAGGTGCAGAATCCGGAGCTGCCCGCGCTGGGCGTCGCCGCCGCCCACGCCCGCGGGCTGATCGAGCGGGACGGGCAGGCGCTGGCCCTGGCCGCCGAACGGCACGACGATCCGTGGGCGCGCGCCTCGGCCGCCGAGGATCTCGCGGTGCTGCTGCGCGCCGCCGATCCCGAGGCGGCGATCGCCCAGCTCGACACCGCCATGGCCGGGTACGACCAGCTGGGCGCCAAGTGGGACGCGGCCCGGGCCCGGCGGCGGCTGCGGGCGCTGGGCGTCCGGCGGCGGCACTGGAACTACGCCGACCGGCCGGTCGGCGGCCGGGCCAGCCTGACCCAGATGGAGGAGACCGTCGCCGCGCTGGTGGTGCAGGGCCTCACCAACCGGCAGGTGGCCAGCCAGCTGTTCGTCTCGCCGCACACGGTGGGCTTCCACCTGCGGCAGATCTTCCGCAAGCTGGGCATCCACTCCCGCATCGATCTGGTCCGCCGGATCTCCTGA	MWVTGDMKTLPGRLEERSVTVIDRPDPPLRNRDAQLARIEAVLRPVGATGKSAVLLAEGPAGSGKSRLVAEAARLGADQGYTVLRGAASRLTQQIPMAPLLAALAVPAPAPEPNSTDVLDRQLGVVGRLEVRLRERLRTGPVLVALDDLQWADPATLLALRMLCSRLAGAPVVWLLVLLGGDRSQELDLLFDALRGRAHTERLDPLAPLCDRASVQLVTDVLGAPPGPEISELVESTNGNPRVVIDLVTGMRDDGAIRVVDGVARLAAVPAIGLAAGAADRRSPGPLPARFRALIGAELAALSPATRQMVQVAAVLGVSFSPDDLCEMLGEPPSRLLPVMQEALHSELMFSRLDDFAFRREPVWRAVLDTVPMPVRVAMHRQAADMLLRREGGIMAAATHLVHGALPGDALAVDLLGRAAEQVLTTSPRTAVTLASRGLELSEPQQPGYLQLAVTAVRALNHAGPLDRAAHVATEVLDEVRPEGEAGARLRQLLSTTLLLQGQAGRGSGLARQILADPRLGPELRDGAEVVQLVALSHTDERAAYQRADAVLAERSGRGAAVAAIALTVRAVGQWREGRVGDALRTVDEAGSLLGDGTDTWHSDPRWTGALMRLRLRKLAEATDMITACTTAAEERGADVVAAVPAILRSGVHLARGELAEAEAAARAGVSAGADHHMPLFAPLAWAVLTTTALRGGDLMAAGEHVRELDRTVLDQSSRPWWALRIWVAARVAGARDGAAAAMGVLVEGYRDAGARRELLLEDYAAAAWCVRAALEAGLPDIAHALAETAHALEVQNPELPALGVAAAHARGLIERDGQALALAAERHDDPWARASAAEDLAVLLRAADPEAAIAQLDTAMAGYDQLGAKWDAARARRRLRALGVRRRHWNYADRPVGGRASLTQMEETVAALVVQGLTNRQVASQLFVSPHTVGFHLRQIFRKLGIHSRIDLVRRIS	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	469.61	gnl|BL_ORD_ID|936|hsp_num:0	1015			426	582	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0001335.1|Borregomycin_3 # 4355 # 7645 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.724	BGC0001335.1|Borregomycin_3 	4355	7645	-	Loose	400	31.5722	IND-6	32.35	3002262	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IND beta-lactamase	ATGAGCGTCTTCGACCTGCCCCGGCTGCACTTCTCCGGGGTAGCCGTCACCCGGTTGCCGACCGGCCCCCGATCCGGCCGGTACGACCTGGGCACCAACCTGGTGCTGACCGACGACGGCCCGTACCCGCCGGCGGCGCCCCCGCAGGAGTACCACGCACTGCTGGAGCGTTCCGGCGTGCGGTTCGAGCCGGACGGCACCATCACCCCCGAGGGCCGGTTCCACTCGGTCAAGGGCTGGAACTTCGGCGGCAACGGGCACTTCTGGGTGGACGCCAAGGTGGTCAGCTGGGAACGCGAGCCCGGGGAGGTCCGGACCGCCGACCCGGTGGTGGGCCGCAACCTCGACATGTGGGGCCACTACAACGACTACCTGGCCACGACGGCCAACCGGGCCCGGGTCTTCGACATCGACCCGGCGTCCAACTGGACCACCACCCTGCTGATCGGCCAGCTCGGCCTGGGCCGGCTCGGCCGCTCCCACGACGTGGAGTACCTGCTGGTCGGCGACGTGACCGGCAACCAGCCGCCGCGCTGGCAGAACAACCGGCACATCGTCGACGTCGGCGAGCACATCCTCGCCCCGCACTTCCGGCGGTCCGTCGTCCACCAGTTCGTGGTGGACCGCAGCCAGGGCCTGCACTGGCTGGCCGGGGCCGACTCCTCGGCGGCGCTGACCGCCCTGCGGGAGCGGGTCGCGGCCGACGACATGGGCGGGCTGCTGGTGCAGTTCGCGCTGACCAACATGGCCAACCCGGTGGCGCCCGACGCGCCCAACTTCTGGGACCTGCGGGGCACCGTGGCACCGTGGCGCCCGGCGGAGCCGCGCAGCCGTCCCGGTGGCCGGCTGCTCAGCGCCCGGCACGCCCGCCCGGCCGAGCAGCCGGCGCCGCTGCACGCCGCCGCGGTCGAGGTCGGCGCCGAGTGGGTGACCGCGAACCTGGTCAACGCCGTCACGGTGACCCACCGCGCCCCCGCCCGCGGCCCCGGGCCGACCCATGCCCTGGGCCCCCGGGTCGACGCCGGCGACCTGGAGCTGCGGGCCGGATCCGACGACCGGGTGATCGCCCGCATCCCGCGGGAGGCCTACCTGTCGGAGACCTACGACCGCACGGCCGGCATCGTGACCGTGCCGCGGCTGCCCGGGCCGCCGGGGGCCGAACCGGAGGCGTTGCGCCTGGTCACGGTCGACGGTGACGGCGAGCCGGTGGTGCTGCTGACCGAGCAGGAGATCACCGTGCACTCCGACGACGACGGGCTGTTCCTGGAGCACCCGGACCGGGTGGCGGGCGACGACCGGGCCGTGCCGGTGACCGTACGGTCGTTCGTCCGGGGCCGGCCCGCGCCGGTCGCCGGCATCGCCGTGCACCAGTTCTTCAACCCGCGCGCGCTGCCGCTGGACCCCTGTGCCCGCGCGGCCGGCGCCCGGGTCACCGACCTGGACATCGTCGAGATCACCGCCGTCGACCCCGCCGAATACGCCCGCACCGCCACGGTCAGCACGGACGAACGGGGCGAGGCGGTGCTGACCGTCCGGGGTGCCCGCGCCGGCGCCACCCAGCTGTTGCTGCTGCCGCCCGGGGAGGAGTTGCCGTGCGACCCGGACGCGCCCGGATCGGCGGTCCGCGCCTACGACAACGACGACCTGCTCGGCTACTGGCCGACGGCCGGCGCGGTCAGCGTGCGGGTGCTCACCGACGACTGGGCGCTGGCCCGGGTCCCCGACGACGAGGTGACCTTCGACCTGCTCTACCGCGAGGTGTTCGCCCCGTACGAGCTGCTCTACTCGTTCATGCGGGAGGAGATCTTCAGCCTGGCCGACCGGTGCAAGGTGGAGACGTATCCGCGGCTGATCTGGCTGATGTGCGACCCGCGGAACAAGGACAAGACCTTCTACATGCCGCCGACCCGCGACATGTCGGAGCCCAAGGCCCAGCTGCTGTTGCGCTACCTGCGCCTGCACGAGGAGCAGCGGCAGTCACCGCCGCGGCGGGCGGCCGAGCGTACGCCGGTCGCCGCGATCACCACCCGCGAACAGCTCGCGGCCGCGCTGCGCCAGGCGGCCACCATCGAACTCGCCGTGATGATGCAGTACCTCTACGCGGCCTGGTCCATCCCGACGGCCGGTGCCGGGGCGGAGCTCGTCCGCCGTGGCGAGTGGACCCCGGAGCAGTTGCAGCTGGCCTGCGGCGACGGCGGTCCGACGCTCGACTACGGGATGCGCGGCACGCTGCTCAACGTGGCCCGGGAGGAGATGATCCACTTCCTGGTCATCAACAACATCATCACCGCCACCGGGGACAGCTTCCACCTGCCGGCGATCGACTTCGGCACCCTCAACGAGCAGCTGCCGGTGCCCCTGGACTTCAGCCTGGAGGGGTTCGGGATCGGGCCGTTGCAGCGGTTCATCGCCATCGAGCAGCCGGACGACCTGACCGTCGAGTTCGCCGGGACCGACACCCTGCTCGACCGGGGCGACGCCATGTACCCGTACGGCTCGCTCAGCGAGCTCTACGCGGCGATCCGGGAGGGCATCCAGCGGGTGCCCGACCTCATCATGGTCGCCAAGGGGCGCGCCGGCGGCGAGCACCACCTGTTCATGCGCGAGTCGGTCAACGCGGTGCACCCGGACTACCAGCTCGAGGTGGACGACGTGGCCAGCGCCGTGTTCGCCATCGACTTCGTCACCGAGCACGGCGAGGGCCACGTCATCGAGTCGGTCAAACCGGACGAGGACTCGCACTTCACCACGTTCCTCAAGCTCTCCGACCTGCTGATGCACCAGCACACCGCCGGGCCGGGCGGGCACCGGGTGCCGTGGACGCCGGCCTACCCGGTGCTGCGCAATCCCACGCTGTTCCCCGGCAACGCGGCCCAGGACCTGGTCACGGCCGAGGCCGCGCGCTCGGCGATGGTGCTGTTCAACCGCTCGTACGCGGTCATGGTGCAGCTGATGATCCAGCACTTCGGCTACCGCCCGGACGGCAGCCTGCGCCGGTCCCGGCTGATGAACGCGGCCATCGACGTCATGACCGGCATGCTCCGGCCGATCGCCGAACTGCTGGTCACGATGCCGTCGGGGCGCCCCGGCCGGACCGCCGGGCCGTCCTTCGAGCTGGCCGTGCCGCCGACCTACATCGCCCGCCCGGACGTGGCCATGCGGGTCATCAGCGGCCAGTTCCAGCAGCTCGCCGGCGACGCGCAGAAGTGCCCCGGCCTGCCCGAGCGGGTCGCCGACCTGATGCGCTTCTACGCCGACTTCTTCGCCCACCTCGATTGGACCCAGCTATGA	MSVFDLPRLHFSGVAVTRLPTGPRSGRYDLGTNLVLTDDGPYPPAAPPQEYHALLERSGVRFEPDGTITPEGRFHSVKGWNFGGNGHFWVDAKVVSWEREPGEVRTADPVVGRNLDMWGHYNDYLATTANRARVFDIDPASNWTTTLLIGQLGLGRLGRSHDVEYLLVGDVTGNQPPRWQNNRHIVDVGEHILAPHFRRSVVHQFVVDRSQGLHWLAGADSSAALTALRERVAADDMGGLLVQFALTNMANPVAPDAPNFWDLRGTVAPWRPAEPRSRPGGRLLSARHARPAEQPAPLHAAAVEVGAEWVTANLVNAVTVTHRAPARGPGPTHALGPRVDAGDLELRAGSDDRVIARIPREAYLSETYDRTAGIVTVPRLPGPPGAEPEALRLVTVDGDGEPVVLLTEQEITVHSDDDGLFLEHPDRVAGDDRAVPVTVRSFVRGRPAPVAGIAVHQFFNPRALPLDPCARAAGARVTDLDIVEITAVDPAEYARTATVSTDERGEAVLTVRGARAGATQLLLLPPGEELPCDPDAPGSAVRAYDNDDLLGYWPTAGAVSVRVLTDDWALARVPDDEVTFDLLYREVFAPYELLYSFMREEIFSLADRCKVETYPRLIWLMCDPRNKDKTFYMPPTRDMSEPKAQLLLRYLRLHEEQRQSPPRRAAERTPVAAITTREQLAAALRQAATIELAVMMQYLYAAWSIPTAGAGAELVRRGEWTPEQLQLACGDGGPTLDYGMRGTLLNVAREEMIHFLVINNIITATGDSFHLPAIDFGTLNEQLPVPLDFSLEGFGIGPLQRFIAIEQPDDLTVEFAGTDTLLDRGDAMYPYGSLSELYAAIREGIQRVPDLIMVAKGRAGGEHHLFMRESVNAVHPDYQLEVDDVASAVFAIDFVTEHGEGHVIESVKPDEDSHFTTFLKLSDLLMHQHTAGPGGHRVPWTPAYPVLRNPTLFPGNAAQDLVTAEAARSAMVLFNRSYAVMVQLMIQHFGYRPDGSLRRSRLMNAAIDVMTGMLRPIAELLVTMPSGRPGRTAGPSFELAVPPTYIARPDVAMRVISGQFQQLAGDAQKCPGLPERVADLMRFYADFFAHLDWTQL	MKRRIQFFMVSMMLTPLFSAQVKDFVIEPPIKKNLYIYKTFGVFGGKEYSANSVYLVTKTGVVLFDVPWEKAQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNNKGIKTYATPKTNQFLKRDGKATSTELIKPGKPYRFGGEEFVVDFLGEGHTADNVVVWFPKYKVLDGGCLVKSNSATDLGYIKEANLEQWPKTMHKLKTKYSEAVLIIPGHDEWKGGGHVEHTLELLDKK	458.58	gnl|BL_ORD_ID|538|hsp_num:0	590			369	564	
BGC0001335.1|Borregomycin_4 # 7660 # 9102 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.757	BGC0001335.1|Borregomycin_4 	7660	9102	-	Loose	600	31.9574	Streptomyces venezuelae rox	44.0	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAGCGACGACCGCGCGGGCACCGTGGCCGTGCTCGGCGCCGGGATCGCCGGGCTGGTCGCCGCGGGCGAGCTGGAGGCGCGCGGCCACCGGGTCACCGTGCTGGAGGGCAGCCCGCGGATCGGCGGCCGGGTCCACACCCACCGCTTCGGCAGCGCCGAGGGCGCGCCGCTGGCCGAGCTGGGCGCCATGCGGATCCCCGGCGACCACACACTGACCATGCGGTACGTGCACCGGCTGGGCCTGGGTGCCCAGCTCCAGCCGTTCCGCACGGTGCTCACCGACGACAACAACTACCTGCGGGTGCAGCAGCGGTTCGTCCGGGCCCGCGAGGCGGCACCGCACCTGGTCGCCCAGCTGCGTCCACTGCTCGGTGCGGCGGTCCACCGGCCGGAGACGATGCTTTTCGGCGCGTGGTTGCTCGCCACGGTCAACGCCATGGCACCGCGCGAGCTGCGGACCGGCGTACGGGCGGACCTCGCCGGCCTGCTCGCCGCGGCCGACGGCCTGGACCTGCGCCCCTTCCTGTACGGCCCGACCGCGGACCGCGTTGACCTGGTGGCGCTGCTGCGCGCGCACCCGGAACTGCGCCGGTTCTGCGGGCCGCGGCTGGACACCTTCCTCGACGACATCGTGCGGGAGGCGGGCGGCGACCAGTGGTACCTGCGCGGCGGCATGAGCCTGATCACCGACCGGCTCGCCGCCCGGCTGTCCGCCCCGGTCCGCACCGGGCAGGAGGTGGTCTCGCTGGCCGTCGACGACGACGGGGTCGGCGTGGGGCTGGACGACGGCCGCAGCCGGTACGTCTCCCGCTACCGCGCGGTGCTGTGCACCATCCCGTTCTCGGTGCTGCGCGGGGTCGCCGTCGACGGCATCGACGACGACAAGCGCCAGGTCCTCGCGGCGGTCGACTACGGCGGCGCCACCAAGATCGCGCTGCACTGCCGGGAGCCGTTCTGGACCCGGTCCGGGATCGCCGGCGGCGCCTCGGCCACCGGCGGACGGCTCCGGCAGACCTACTACCCGCCGGTGGAGGGCGATCCGCGGCTCGGCGCGGCGCTGCTGGCCAGCTACGCGATCGCGGAGGACGCCGCGGTGCTCGGCGCGCTGCCCGAGCCGGAACGCCACGCGGCGGCCGTCGAGGAGGCCGCGGCCCTGCATCCGGAGCTGCGGGAACCGGGCATGGTGCTGGGCGCGGCCAGCCTGGCCTGGGACGGCTACCGGTGGAGCAAGGGCTGCACCGCCCGCCGGTGGGGCAAGACCGCGACGGAGACCGCGGAGGAGATCCGGCGGGCCGCCCGCCGCCAGGGCGGCCTGTTCTTCGCCGGCGAGCACTGCTCGTCGATGCCCGCCTGGATCAACGGGGCGATCGAGTCGGCGCTCACCACGGTGGCCGAGGTCGACGCGTTCACCCGTGACCCCCAGCACGCCGCCCACGCCTGA	MSDDRAGTVAVLGAGIAGLVAAGELEARGHRVTVLEGSPRIGGRVHTHRFGSAEGAPLAELGAMRIPGDHTLTMRYVHRLGLGAQLQPFRTVLTDDNNYLRVQQRFVRAREAAPHLVAQLRPLLGAAVHRPETMLFGAWLLATVNAMAPRELRTGVRADLAGLLAAADGLDLRPFLYGPTADRVDLVALLRAHPELRRFCGPRLDTFLDDIVREAGGDQWYLRGGMSLITDRLAARLSAPVRTGQEVVSLAVDDDGVGVGLDDGRSRYVSRYRAVLCTIPFSVLRGVAVDGIDDDKRQVLAAVDYGGATKIALHCREPFWTRSGIAGGASATGGRLRQTYYPPVEGDPRLGAALLASYAIAEDAAVLGALPEPERHAAAVEEAAALHPELREPGMVLGAASLAWDGYRWSKGCTARRWGKTATETAEEIRRAARRQGGLFFAGEHCSSMPAWINGAIESALTTVAEVDAFTRDPQHAAHA	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	100.84	gnl|BL_ORD_ID|4833|hsp_num:0	5820			291	441	rifampin; rifaximin; rifapentine
BGC0001335.1|Borregomycin_5 # 9378 # 9902 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.777	BGC0001335.1|Borregomycin_5 	9378	9902	+	Loose	990	25.0238	farB	39.29	3003962	protein homolog model	n/a	n/a	antibacterial free fatty acids	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGTCCCGGTCCCGAACCGTTCTTCTCCCCGTCCCGGCCGTGCGGACGGCGGCGCTCGGCGGGCGTGTCGCCGCGGTGGCCTATCTGTGCTGGGTGGACTGGCGGCTGGCCGCCGTGATGCTGCTGCCCGCGGCGGTGGGCACGGTCGTGGTCCGCCGCCGGCTCGCCGCGCACCGCGAGGGGATGCGGCAGACCCGGCCCGCCCTCATGGAGCTGGACCGGTACGCCCGGGAGCTCGCGCAGGCCCCGCCGGCCCCGGCCGGGGCGGCGCATGACCGGTACACGGCGGCCCGGGCGGAGTTCGGCGGCCGCTTCGCGACCGGCATCGGCCGGATCGGCCCGCTCACCGCGACCACCGAGGTGATCTTCGCGCCGGTCACCACGCTCTGTCTCACCCTGGTCGCCGGCAGCGCGCTGGCCGCAGCGGGGGCTCTGCGGCCACTCGATCTGGTGCCCTTCCTGCTGCTGGCCGGCGTCGTCGCGGGTGCCGTCCCGGCGGCGGCGCAGCTTGCGGGTGGCCGGTGA	MSRSRTVLLPVPAVRTAALGGRVAAVAYLCWVDWRLAAVMLLPAAVGTVVVRRRLAAHREGMRQTRPALMELDRYARELAQAPPAPAGAAHDRYTAARAEFGGRFATGIGRIGPLTATTEVIFAPVTTLCLTLVAGSALAAAGALRPLDLVPFLLLAGVVAGAVPAAAQLAGGR	MDYPPLKGAALAWVTLSLGLAVFMEVLDTTIANVAVPVIAGNLGAATTQGTWVITSFSVANAVSVPLTGFLAKRIGEVKLFTAAAVGFVITSWLCGIAPNLQSLVVFRILQGFIAGPLIPLSQSLLMASYPPAKRTLALALWAMTVVVAPVLGPILGGWISGNWHWGWIFFINIPIGIISAWITWKHLKYRETETVKMPTDYVGLTLMVVGIGALQMMLDRGKELDWFASGEIITLGVVALVCLSYFIVWELGEKYPIVDLSLFKDRNFTVGVIATSLGFMVYMGTLTLLPLVLQTNLGYTSTWAGLAAAPVGILPVFLSPLIGRFGNKIDMRLFVTASFLTFAFTFYWRTDFYADMDIGNVIWPQFWQGVGVAMFFLPLTTITLSHMKGGQIAAAGSLSNFLRVLMGGVGVSVVSTLWERREALHHTRFAEHITPYSATLHETAAHLSQHGVSDIQTLGIINNTITQQGFIIGSNEIFMAGSLLFIIMIPVIWLAKPPFHNGGGGGH	34.25	gnl|BL_ORD_ID|2190|hsp_num:0	2429			1122	1206	palmitic acid; oleic acid; linoleic acid
BGC0001335.1|Borregomycin_6 # 9899 # 10675 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.799	BGC0001335.1|Borregomycin_6 	9899	10675	+	Loose	500	27.335	OXA-504	29.59	3005734	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGACCGGCCGACTGCGCGACCTCGTGGACGCCGACGGCCGGCGGCTGGTGCGCGGCGCCGCCCGGCCGGCTGTCCTGGCCGGCGCGGCCGAGGGCGCGGTGGCGGCCATGACGGTCCCGGCCGTGCTGGCGATCGTGCGCTCGCCCGCCGACGGCGCGTGGCCCTGGCTGCTGGCGATCGTGGTGACCGCCGCCGGGGCGGCGTGGGCCGGCTATCGGGCCACTGTGGCCGGTTATCGGGCCGGGGCGGCGCTCCTCGCGAGTGTCCAGCGCCGGGCCGGCGAGCTGCTGCGCGACGGCGAGAATCCGGGCGAGAGCGTGGTGCACGGCGCCACCCGGGACGCCATGGCGGTGTCGAGCCTGCCGGCCCACCTGCTGCGCCCGTGGGCCTCGGCGGGGGCCGTGCCGGTGGGTGCGGCCCTGCTGGTGGGTGCCGTCGACTGGCGACTCGCTCTGGTGGTGGCCGCGACGTTGCCGGTGTCCGCCGTGCTGTTGCGCGCGACGGCGGCCGGACGGCCGCTGCCCGGCTGGGCGGGCTGGGCCGGCGCGGCGGTGGTCCTGGTGGTGGTGCTCGGCGGCGACCGGCTGCTGTCCGGGACGCCGGACGACGCCCGGCTCGCCGCCGTGGCGGTGCTGGCGGTGCAGCTGGCCACGCCGCTGGTGCGCCTGGCCGGCCTGGTCGCGACCGCGTCGGCCGGGGTGGCCGCCCTCGCCCGGGTACGGGTCTGGGCGGCCCCTCACTCCACCGGCGCGCGGTCGGGCAACCCCCTGAACTGA	MTGRLRDLVDADGRRLVRGAARPAVLAGAAEGAVAAMTVPAVLAIVRSPADGAWPWLLAIVVTAAGAAWAGYRATVAGYRAGAALLASVQRRAGELLRDGENPGESVVHGATRDAMAVSSLPAHLLRPWASAGAVPVGAALLVGAVDWRLALVVAATLPVSAVLLRATAAGRPLPGWAGWAGAAVVLVVVLGGDRLLSGTPDDARLAAVAVLAVQLATPLVRLAGLVATASAGVAALARVRVWAAPHSTGARSGNPLN	MPRMLLSSLLAAGLFCALPASAASGCMLFADGTGKPVSTQGDCAAQLTPASTFKIPLALMGYDSGFLVDEQLPALPFKAGDPDFLPEWKQTTTPSSWMQFSVIWYSQRLTEWLGEARFQHYVDSFDYGNRDLEGNPGKHDGLTQAWLSASLAISPQEQARFLGKMVSGKLPVSAQTLRHTANLMRQPDIDGWQIHGKTGMGYPKLLDGSLDREQQIGWFVGWASKQDKTLIFVHTVIQTPGKQFASLRAREEVFAALPARLKTL	97.73	gnl|BL_ORD_ID|3769|hsp_num:0	4839			483	768	cloxacillin; oxacillin; cefalotin
BGC0001335.1|Borregomycin_7 # 10636 # 11214 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.732	BGC0001335.1|Borregomycin_7 	10636	11214	-	Loose	400	24.6386	ErmW	50.0	3001306	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGAACGGAAGTCAGCGCGGCAACGGAAGTCAGCGCGAGCGCGTGCCCGAGCCCGGGGCGGGTCCGACCACGGACCTGCTCCGGGACAGCCGGTCGCTGCGCGGCATCTTCAGCAGCTTCGCGACCGGGGTCACCGTGGTGACGGTCGGCGGCGACAGCCCGCATGCGATGACGGCGAACTCGTTCACCTCCGTGTCGCTCGATCCGCCGCTGATCCTGGTCTGCGTGGAGTGCGACGCCGCCATGCACGGCAGCCTGCTGGAGGTCGGCTCGTTCGGCGTCTCGGTGCTGGCGGCGGACCAGCAGCACGTCGCGCTGCTCTACGCCAACCGGTGGCGGCCCCGCGATCCCACCCAGTTCGACCGGCCGGGATGGGCTCGCGGGGCGCGCACCGGGGCGCCGCTGGCGCGGGGCGCGCTGGCGTGGTTCGAGTGTGCGCTGTGGCGGGCGTACGACGCCGGTGACCACTCCATCTTCGTCGGCCGGCTGCTCACCGCGGAACGCCACGACCGCCGGGACGCCCTGGTCTACCACTCCGGTCAGTTCAGGGGGTTGCCCGACCGCGCGCCGGTGGAGTGA	MNGSQRGNGSQRERVPEPGAGPTTDLLRDSRSLRGIFSSFATGVTVVTVGGDSPHAMTANSFTSVSLDPPLILVCVECDAAMHGSLLEVGSFGVSVLAADQQHVALLYANRWRPRDPTQFDRPGWARGARTGAPLARGALAWFECALWRAYDAGDHSIFVGRLLTAERHDRRDALVYHSGQFRGLPDRAPVE	MSSIRRRHAAASLDTPAVGGRHELGQNFLVDRGVCTRIAEVVSSTTAHPVLELGAGDGAITRALVAANLPVTALELDPRRVRRLQRTFADGVTVVHGDMLRYDFGPYPHHVVSTVPFSITTPLLRRLIGQRFWHTAVLLVQWEVARKRAGVGGTTMLTAASWPWYEFTLVERVPKTSFDPVPSVDGGILVIERRSAPLLDDRCVGDYQNLVREVYTGPGRGLAAILRTRLPGREVDAWLRRERVDPAALPRDLKAGHWASLYRLYREVGTRPAPAGRSVRARPGSVGPDRSLPPRGLRSGPPRARRRGGGA	61.74	gnl|BL_ORD_ID|1572|hsp_num:0	1714			207	285	erythromycin; josamycin
BGC0001335.1|Borregomycin_8 # 11239 # 12828 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.679	BGC0001335.1|Borregomycin_8 	11239	12828	-	Loose	350	26.5646	TMB-1	35.14	3004105	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin	antibiotic inactivation	TMB beta-lactamase	GTGGACAACCGCATCAACCGGATCGTCATCCTCGGCGGCGGGACCGCGGGATGGATGACCGCCTCCTACCTGGCGAAGGCGCTCGGTGACACCGTCACGATCACCCTGCTGGAAGCACCGGCGATCGGCCGGATCGGGGTCGGCGAGGCCACCGTGCCCAACCTGCAGCGCGTGTTCTTCGACTTCCTCGGCCTCCGCGAGGAGGAGTGGATGCCGGAGTGCAACGCCGCGTTCAAGACGGCCGTGAAGTTCATCAACTGGCGTACCCCCGGGCCCGGCGAGGCCAAGGCCCGCACGATCGACGGCCGGCCGGACCACTTCTACCACCCGTTCGGGCTGCTGCCCGAGCACGGCCAGGTGCCGCTGTCGCACTACTGGGCCTACAACCGGGCGGCCGGCACCACCGACGAGCCGTTCGACTACGCCTGTTTCGCCGAGACCGCCGCCATGGACGCGGTCCGCGCGCCCAAGTGGCTCGACGGGCGGCCCGCCACCCGGTATGCCTGGCACTTCGACGCCCACCTGGTCGCCGAGTTCCTGCGCCGGCACGCCACCGAGCGGCTCAACGTGGAGCACGTGCAGGGTGAGATGCAGCAGGTGCTGCGCGACGAGCGGGGCTTCATCACCGCCCTGCGCACGGTCGAGGGCCGGGACCTCGAGGGTGACCTGTTCATCGACTGCTCCGGCTTCCGCGGCCTGCTGATCAACAAGGCCATGGAGGAGCCCTTCATCGACATGAACGACCAGCTGCTGTGCAACCGCGCGGTGGCCACGGCGATCAAGCACGACGACGACGCGCACGGGGTCGAGCCGTACACCTCGGCGATCGCCATGCGGTCCGGCTGGAGCTGGAAGATCCCGATGCTGGGCCGCTTCGGGACCGGCTACGTCTACTCCAGCCGGTTCGCCGAGAAGGACGAGGCCACCCTCGACTTCTGCCGGATGTGGGGCCTGGACCCGGAGAACACCCCGCTCAACCAGGTGGCCTTCCGGGTCGGCCGCAACCGCCGGGCCTGGGTGAAGAACTGCGTGAGCATCGGCCTGGCGTCGTGCTTCCTGGAGCCACTGGAGTCCACCGGCATCTACTTCATCACCGCGGCCATCTACCAGCTGACTCAGCACTTCCCGGACCGCACCTTCGCGCTCGCGTTGAGCGACGCGTTCAACCACGAGATCGAAGCCATGTTCGACGACACCCGGGACTTCATCCAGGCGCACTTCTACGTGTCGCCGCGCACCGACACGCCGTTCTGGAAGGCGAACAAGGACCTGCACCTGCCCGAGCAGATGCGCGAGAAGATCGCGATGTACAAGGCCGGCCTGCCGATCAACGCGCCGGTCACCGACGAGTCGACCTACTACGGCAGGTTCGAGGCCGAGTTCCGCAACTTCTGGACCAACGGCAGCTACTACTGCATCTTCGCGGGCCTCGGGCTGCGCCCGGACAACCCGCTGCCGATGCTGCGACACCGTCCGGAGCAGGTCCGCGAGGCGCAGGCGCTGTTCGCCGGGGTGAAGGACAAGCAGCGGGAGTTGGTGGAGACGCTGCCGAGCAACCTGGAGTTCCTGCGCAGCCTGCACGGCAAGTAG	MDNRINRIVILGGGTAGWMTASYLAKALGDTVTITLLEAPAIGRIGVGEATVPNLQRVFFDFLGLREEEWMPECNAAFKTAVKFINWRTPGPGEAKARTIDGRPDHFYHPFGLLPEHGQVPLSHYWAYNRAAGTTDEPFDYACFAETAAMDAVRAPKWLDGRPATRYAWHFDAHLVAEFLRRHATERLNVEHVQGEMQQVLRDERGFITALRTVEGRDLEGDLFIDCSGFRGLLINKAMEEPFIDMNDQLLCNRAVATAIKHDDDAHGVEPYTSAIAMRSGWSWKIPMLGRFGTGYVYSSRFAEKDEATLDFCRMWGLDPENTPLNQVAFRVGRNRRAWVKNCVSIGLASCFLEPLESTGIYFITAAIYQLTQHFPDRTFALALSDAFNHEIEAMFDDTRDFIQAHFYVSPRTDTPFWKANKDLHLPEQMREKIAMYKAGLPINAPVTDESTYYGRFEAEFRNFWTNGSYYCIFAGLGLRPDNPLPMLRHRPEQVREAQALFAGVKDKQRELVETLPSNLEFLRSLHGK	MRPFLFLIIFISHFAFANEEIPGLEVEEIDNGVFLHKSYSRVEGWGLVSSNGLVVISGGKAFIIDTPWSESDTEKLVDWIRSKKYELAGSISTHSHEDKTAGIKWLNGKSITTYASALTNEILKREGKEQARSSFKGNEFSLMDGFLEVYYPGGGHTIDNLVVWIPSSKILYGGCFIRSLESSGLGYTGEAKIDQWPQSARNTISKYPEAKIVVPGHGKIGDFELLKHTKVLAEKASNKANHGDR	215.92	gnl|BL_ORD_ID|2393|hsp_num:0	2773			291	390	ceftazidime
BGC0001335.1|Borregomycin_9 # 12855 # 13601 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.714	BGC0001335.1|Borregomycin_9 	12855	13601	-	Loose	550	31.5722	RlmA(II)	31.4	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGACCACCAAGATGTCGCCGGATGCGGCCGACACCGAGGAGCCGTTCTTCGACGACCTCGCCGAGCTCTACGAGCGGTTCATCCACGTGATGGACTCCGACCGGAGTCCCGTGCGGTCCTGGCTGCGCGAGCAGCTCACCGGCGGGCGGCGGGCGCTGGACCTCGGCTGCGGCGGGGGACGCAACTCGGTCCTGCTGGCCGAGAAGTACGACGAAGTGCTCGGCGTCGACATCAGCCAGCGGATGCTCGACATCGCCGCCGGCACCCACGCCCGGCCGAACGTCCGGTACGAGCGGCGCGGGCTCAGCGACCTGGCCCCGGACACCGACGGGGTCTTCGACGTGGTGCTCGCCGTGAACGCGCTGTTCCACATGGGACCGGCCGAGCGCACCCTGCCGCGGGTCCGGGATCTGATCGCGCCCGGCGGCAAGCTGGTGGTGGTCGACGTGGTGCACGACGAGAACGTGGACACCGACGCGCCGGACTGGCAGACCCCGTACGTCTTCCACACCGCGGAGATGGTCTACCGGATCTCCGGGGACGCCGACGCGGCCGCCGACTCGGTCCGGCTCATGCTGCACCCGACCTGGCTGGCCATGAGCCGGCAGACCGTACCGCTGCGCCGGCCGGAGTTCGTCCGGGCCTACGCGGACGCGCTGCCCGGCGCCGTCTTCACCGAAACCCTCAACCCGACCCTCATGGGCGTGGTCTGGTCAGCGCCGGACCCGTCCGCACGTGCCGTCTGA	MTTKMSPDAADTEEPFFDDLAELYERFIHVMDSDRSPVRSWLREQLTGGRRALDLGCGGGRNSVLLAEKYDEVLGVDISQRMLDIAAGTHARPNVRYERRGLSDLAPDTDGVFDVVLAVNALFHMGPAERTLPRVRDLIAPGGKLVVVDVVHDENVDTDAPDWQTPYVFHTAEMVYRISGDADAAADSVRLMLHPTWLAMSRQTVPLRRPEFVRAYADALPGAVFTETLNPTLMGVVWSAPDPSARAV	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	87.94	gnl|BL_ORD_ID|2052|hsp_num:0	2274			297	546	tylosin; mycinamicin
BGC0001335.1|Borregomycin_10 # 13925 # 15541 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.754	BGC0001335.1|Borregomycin_10 	13925	15541	+	Loose	900	125.561	iri	30.74	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGCACCGCGCACCCCGCACACCGACGTCCTCGTCGTCGGCGGCGGACCGGTCGGTCTGTCGCTCGGGCTGGAGCTGAGCCGGCACGGCGTCGACCATCTGCTGCTCGAGGCCGGCGACGGGCAGATCCAGCACCCCCGGGTGGGCACGGTCGGTCCCCGGACCATGGAGCTCTACCGCCGCTGGGGGGTGGCCGACACCATCCGGCAGGCCGGCTGGCCCGACGACCACCCGCTGGACATCGCCTGGGTCACCGCGCTGGGCGGGCACGAGATCTTCCGGATCCCGGTCGGCACCGCGGCCGGACGCGTCGCGCCGCCGTACACGCCGGAACCGGAGCAGGTCTGCCCGCAGCACTGGCTGCAGCCGCTGCTGACCGCGCGGCTGCGCGGCGCGGCGGGCAGTGTCCGGCTGGGGCACCGGCTCGACGGCTTCGTGCAACACGACGACCGGGTGGAGGCCACGGTGTCCGACGTGGACACCGGTACGACCCGGACGGTGACGGCACGTTTCCTGGTCGCGTGCGACGGTGCCGCCTCGCCCGTCCGCAAGGCGTGCGGCATCGGGGTGCCGTCCCGGCATCCCACCCAGATCTTCCGCAACGTGCTGTTCCGCGCGCCGGAGTTGCGCAAGCAGCTGGGTGACGCGGCCGCGCTGGTCTACTTCCTCACCTCACCGCGGCTGCTGCGGTACCCGCTGCGGTCGATGGACGGCCGGGACCTCTACCGGCTCACCGCCCGCGGCGCCGACGACGACGCCACCCCCACCGACCCGTACGCGCTGATCAACGAGGCGCTGGCGGTCAGCACGCCGGTGGAGGTGCTCTCCGACGAGAACTGGCACCTCACCCACCGGGTGGCCACGGCGTACCGGCAGGGACGGGTGTTCCTCTGCGGCGACGCCGCGCACACCCTGTCCCCCTCGGGCGGCTTCGGCATGAACACCGGGGTGGCCGACGCCGCCGACCTGGGCTGGAAGCTCGCCGCCGAGCTGGCCGGCTGGGCGGGCGGGCGGCTGCTGGACAGCTACGCCGCCGAACGAATGCCGGTGGCCGAGGCCAGCCTGGAGCAGTCCCACCGGAACCTGACCCGTACCACCGGCCGGAGCCTGCCGCCGGAGATCGTGGCCGACACCGCCGAGGGCGCGCGGGCCCGGGCGGCGCTGGCCGAGCGGATGGCCGCCGAGGGGGTGGGCCGGGAGTTCGACGCGCCGGACCTGCACTTCGGCTACCGCTACCGGTCCGAGCTGATCGTGGCCGACCCGGACCCGGGCGAACCCGGCGAGGACTGGTCGACCAGCGCCCTGCCGGGCGGGCGGGCGCCGCACGCCTGGATCGCCCCGGGCATCTCCACGCTGGACCTGATCGGCACCGGCTTCACCCTGCTGCACCTGCCGCACGGCGGGACCGCGGACGAGGACGCCGCGGTCGGCGCCGCACGCCGGGCCTTCGCCGGCGCCGGTGTCCCGCTGACCGTGCACGAGCTGCGCGACGACCACATCCGCCGGCTGTACCGCCGGGCGTTCGTGCTGATCCGCCCGGACGGTCACGTCAGCTGGCGGGGCGACCGCCTGCCGGCCGACCCGCGGGCGCTCGCGGACGCCGTCCGCGGTGCGTGA	MAPRTPHTDVLVVGGGPVGLSLGLELSRHGVDHLLLEAGDGQIQHPRVGTVGPRTMELYRRWGVADTIRQAGWPDDHPLDIAWVTALGGHEIFRIPVGTAAGRVAPPYTPEPEQVCPQHWLQPLLTARLRGAAGSVRLGHRLDGFVQHDDRVEATVSDVDTGTTRTVTARFLVACDGAASPVRKACGIGVPSRHPTQIFRNVLFRAPELRKQLGDAAALVYFLTSPRLLRYPLRSMDGRDLYRLTARGADDDATPTDPYALINEALAVSTPVEVLSDENWHLTHRVATAYRQGRVFLCGDAAHTLSPSGGFGMNTGVADAADLGWKLAAELAGWAGGRLLDSYAAERMPVAEASLEQSHRNLTRTTGRSLPPEIVADTAEGARARAALAERMAAEGVGREFDAPDLHFGYRYRSELIVADPDPGEPGEDWSTSALPGGRAPHAWIAPGISTLDLIGTGFTLLHLPHGGTADEDAAVGAARRAFAGAGVPLTVHELRDDHIRRLYRRAFVLIRPDGHVSWRGDRLPADPRALADAVRGA	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	112.32	gnl|BL_ORD_ID|729|hsp_num:0	796			3	1374	rifampin; rifaximin; rifabutin; rifapentine
BGC0001335.1|Borregomycin_11 # 15590 # 16843 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.731	BGC0001335.1|Borregomycin_11 	15590	16843	+	Loose	550	60.4622	Nocardia farcinica rox	31.01	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACCGAGCCGACGACGATCACCACCACCGTCTGCGTGGTCGGCGGCGGGCCGGCCGGCGCCATGCTCGGGCTGCTGCTCGCCCGGGCCGGCATCGACGTGGTGGTGCTGGAGAAGCACGCCGACTTCCTGCGCGACTACCGGGGCGACACCATCCACCCGTCGACCCTGGAGGTGCTCGACGAGCTGGGCCTGTCGCGACGCTTCCACGAGATCCCGCACTCCAAGGTGGAGACCATCCGGTTCGTCCAGGACGGGCGGGCGGTGGACTTCGCGGACTTCCGGCGGCTGAAGCTACGGTTCCCGTACATCGCGTTCGTGCCGCAGTGGGACTTCCTCGACCTGATCACCGGGGAGGCGCGCCGCTATCCGCAGTTCCGGCTGCTGATGCGGACGCCGGCGACCGACGTGCTGCGCGACGGCGGCCGGGTCACCGGCGTCCGGGTGCGCTCACCGCAGGGCGAGGCCACGGTACGGGCGGCGCTCACCGTCGCCGCCGACGGCCGGCACTCGGTCCTGCGCGCGGCGGCCGGGCTGCGGCCACGGCAGTACGGCGTACCGATGGATGTGATCCTGTTCCGGATCTCCCGGCGCCCCGACGACCCGGACGAGGGCCTGAGCGTCCGGATCGGCAACGGCCGGGTGATGGGCGCGATCCGCCGCACCGACTACTGGCAGGTGTCCTACGAGGTACCCAAGGGCGGCTACGAGGCGCTGCGCCGGCAGGGCATCGACCGGCTCCGGGCCGACCTCGCCGAGCTGGTGCCGTTCCTGGCCGACCGGGCCGGCGAGCTGCGGGGCTTCGAGGACACCAACCTGCTGGACGTGCGGATCGACCGGATGCCGCGCTGGTACCACCCGGGACTGCTGTTCATCGGCGACGCCGCGCACGCGATGTCGCCGGTGGGCGGATTCGGGGTCAACCTGGCGGTCCAGGACGCGGTGGCCGCGGCGAACCTGCTCGCCGGGCCGTTGCAGCGCTACCAGGCGGACGGCACACCCTTCGACCGGGCCGCCGCCGCCGTGCAACGCCGCCGGCAGGTCGCCACCGTCATCACCCAGGCGCTGCAACGGGTGACCCAGCGGCTGGGCACCAAGCGGGCCCTGGCCGGCGACGCGGTGCTGCGGGGTCCCGACCCGTCGGCGTTCTACCACCGGATCCCGTTCCTCCAGCGGATCATGAGCCGGATGACCGCCGTCGGCTTCCAGCCGGAACATGTGCGCAGCCCCGCGGCGGTCGCCGCCGAGGACTGA	MTEPTTITTTVCVVGGGPAGAMLGLLLARAGIDVVVLEKHADFLRDYRGDTIHPSTLEVLDELGLSRRFHEIPHSKVETIRFVQDGRAVDFADFRRLKLRFPYIAFVPQWDFLDLITGEARRYPQFRLLMRTPATDVLRDGGRVTGVRVRSPQGEATVRAALTVAADGRHSVLRAAAGLRPRQYGVPMDVILFRISRRPDDPDEGLSVRIGNGRVMGAIRRTDYWQVSYEVPKGGYEALRRQGIDRLRADLAELVPFLADRAGELRGFEDTNLLDVRIDRMPRWYHPGLLFIGDAAHAMSPVGGFGVNLAVQDAVAAANLLAGPLQRYQADGTPFDRAAAAVQRRRQVATVITQALQRVTQRLGTKRALAGDAVLRGPDPSAFYHRIPFLQRIMSRMTAVGFQPEHVRSPAAVAAED	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	88.16	gnl|BL_ORD_ID|4834|hsp_num:0	5821			9	888	rifampin
BGC0001335.1|Borregomycin_12 # 16935 # 17396 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.688	BGC0001335.1|Borregomycin_12 	16935	17396	+	Loose	525	30.4166	OXA-926	32.56	3005323	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACGGCCGGAATCGGCGTGCTGCTGGCTCTCACGTGTGCGACCTGGTTCAACAATGCGCTGCAGTGGTACACCCAGTTCACGACCTACGGCCTGTTCTCCGCCATCGCCGACCAGACCGGCGATGAGGGATTCGTGCGCTATCACAAGGCCTATCAGAAGCGGCTGCCCGCGACGATCTACGTGCCGTTCGGCATCCTGATGGTCCTCAGCGTGACGGCGCTGTTCGTCCGCCCGGACGAGCTGGGCGTGGGCGGTGCCGTGCTGCTGCTGGTCCTCAACGCGGCGATCGGCGCGATCAGCGGGGCGCTGGCCGCGCCGGTGCACATGCGGGTCGACCGGCAGGGCCGGCTGGAGGCGTCCGACGCCGCGGCGCTGCTGCGCTGGAACGCGTGCCGGCTGGCGGTCGCCACGGCCAGCAGCATCGCGGTCACCTACTTCCTGGTGCAGGCGATCGACTGA	MTAGIGVLLALTCATWFNNALQWYTQFTTYGLFSAIADQTGDEGFVRYHKAYQKRLPATIYVPFGILMVLSVTALFVRPDELGVGGAVLLLVLNAAIGAISGALAAPVHMRVDRQGRLEASDAAALLRWNACRLAVATASSIAVTYFLVQAID	MCNRILQVAAVSVVFLFSAPFATAHELCTLIADADSGRVLLQRGSACSGRVTPASTFKLAISLMGYDAGVLKDAAQPALSYQAGYPDWGGDAWRRDITPTTWIRNSVFWYSQQVVKRVGQERFAQYVKAFQYGNADVSAVPVDDPGQSGAWVMSSLRISPKEQLAFMRKIVRRQLPVSAHAFDMTALIANYGAPVDGWTVHGKTGTGSPGRNNRYDASRAYGWYVGWATKGARRLAFARLIQDEQAIKPNAGLRARDELLRLLPAIDH	57.09	gnl|BL_ORD_ID|3027|hsp_num:0	4055			288	393	cloxacillin; oxacillin; cefalotin
BGC0001335.1|Borregomycin_13 # 17467 # 17643 # 1 # ID=1_13;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.650	BGC0001335.1|Borregomycin_13 	17467	17643	+	Loose	575	21.1718	LUT-3	56.25	3006945	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	LUT beta-lactamase	ATGGGCGACATTCCGCAGTCCGAACGCGGCGTCATGGGCATCAATGTCTTCACCATCGAGCCGGAGAACCAGGAGCCGCTGATCGAATGCATGCGCGGGCTGGGCCGCCGCGAGGACATTCCCGGCCTGCTGGGGCTGCGCCTGCTGCGCAGTGTGGACGGCAAGCGCATGATCAAT	MGDIPQSERGVMGINVFTIEPENQEPLIECMRGLGRREDIPGLLGLRLLRSVDGKRMIN	MNVILNRRTFLLASAVVSASYSLGTLAGANRDDASFQDRLAKLEQKLNGRLGVCAIDTANGAQLGYRANERFAMNSTFKVMLASAFLARSQDEPGLLEERLMYTRADLVTYSPVTEKHVSTGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIPGDPRDTSTPQAMAMSLQRLALGDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDKTGTGDYGSANDVAILWPPRRAPVVLALYSALENQQAEARNDVLADAARIVAEWVTG	19.93	gnl|BL_ORD_ID|3686|hsp_num:0	4756			258	306	
